Meeting Coverage:

World Ophthalmology Congress

WOC: 2018

Advances in CXL

Show Description +

Raj K. Rajpal, MD, reviews the path of CXL development from 2003 to present and discusses what's potentially ahead, including a new CXL clinical trial launching in the United States. The study is designed to look at formulations of riboflavin that can better penetrate the epithelium and an expanded role for oxygen.

Posted: 6/17/2018

Up Next


Neuroprotection for Retinal Disease

Baruch D. Kuppermann, MD, PhD

Hot Topic: Artificial Intelligence

Lama A. Al-Aswad, MD, MPH, R.V. Paul Chan, MD, FACS

The World Burden of Cataract Surgery

Jorge L. Alió, MD, PhD, FEBO

Hot Topic: Preventing Myopia

Arshad M. Khanani, MD, Lisa M. Nijm, MD, JD

EDOF vs Trifocal IOLs: Pro EDOF

Gerd U. Auffarth, MD, PhD, FEBO

Vitrectomy for DME

J. Fernando Arevalo, MD, FACS

Advances in CXL

Raj K. Rajpal, MD

Advances in CXL

Raj K. Rajpal, MD, reviews the path of CXL development from 2003 to present and discusses what's potentially ahead, including a new CXL clinical trial launching in the United States. The study is designed to look at formulations of riboflavin that can better penetrate the epithelium and an expanded role for oxygen.

Posted: 6/17/2018


Please log in to leave a comment.

More From WOC: 2018 Coverage

Neuroprotection for Retinal Disease

Baruch D. Kuppermann, MD, PhD

Hot Topic: Artificial Intelligence

Lama A. Al-Aswad, MD, MPH, R.V. Paul Chan, MD, FACS